Life course variations in the associations between FTO and MC4R gene variants and body size by Hardy, Rebecca et al.
Life course variations in the associations between
FTO and MC4R gene variants and body size
Rebecca Hardy1, , Andrew K. Wills1, Andrew Wong1, Cathy E. Elks2, Nicholas J. Wareham2,
Ruth J.F. Loos2, Diana Kuh1 and Ken K. Ong2
1MRC Unit for Lifelong Health and Ageing, Department of Epidemiology and Public Health, University College London,
London WC1B 5JU, UK and
2MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital Box
285, Cambridge CB2 0QQ, UK
Received July 22, 2009; Revised September 24, 2009; Accepted October 29, 2009
The timing of associations between common genetic variants for weight or body mass index (BMI) across the
life course may provide insights into the aetiology of obesity. We genotyped variants in FTO (rs9939609) and
near MC4R (rs17782313) in 1240 men and 1239 women born in 1946 and participating in the MRC National
Survey of Health and Development. Birth weight was recorded and height and weight were measured or
self-reported repeatedly at 11 time-points between ages 2 and 53 years. Hierarchical mixed models were
used to test whether genetic associations with weight or BMI standard deviation scores (SDS) changed
with age during childhood and adolescence (2–20 years) or adulthood (20–53 years). The association
between FTO rs9939609 and BMI SDS strengthened during childhood and adolescence (rate of change:
0.007 SDS/A-allele/year; 95% CI: 0.003–0.010, P < 0.001), reached a peak strength at age 20 years (0.13
SDS/A-allele, 0.08–0.19), and then weakened during adulthood (20.003 SDS/A-allele/year, 20.005 to
20.001, P 5 0.001). MC4R rs17782313 showed stronger associations with weight than BMI; its association
with weight strengthened during childhood and adolescence (0.005 SDS/C-allele/year; 0.001–0.008, P 5
0.006), peaked at age 20 years (0.13 SDS/C-allele, 0.07–0.18), and weakened during adulthood (20.002
SDS/C-allele/year, 20.004 to 0.000, P 5 0.05). In conclusion, genetic variants in FTO and MC4R showed simi-
lar biphasic changes in their associations with BMI and weight, respectively, strengthening during childhood
up to age 20 years and then weakening with increasing adult age. Studies of the aetiology of obesity span-
ning different age groups may identify age-speciﬁc determinants of weight gain.
INTRODUCTION
Genome-wide association (GWA) studies have recently ident-
iﬁed common genetic variants that are robustly associated with
higher BMI in adults. A GWA study initially for type 2 dia-
betes identiﬁed a common variant in FTO (rs9939609)
which conferred increased risk for diabetes secondary to its
associations with greater adult body mass index (BMI) (1).
A second GWA study reported a common variant
(rs17782313) 200 kb downstream of its nearest gene MC4R
to give the next strongest association with adult BMI and,
unlike FTO, this variant was also associated with taller adult
stature and therefore was more strongly associated with
body weight than with BMI (2). The associations between
these FTO and MC4R variants with BMI and obesity risk
have since been widely replicated in adult populations (3).
Their associations with weight and BMI have also been
demonstrated in children (1,2); indeed the original report of
the MC4R variant described an apparent stronger association
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in energy expenditure, in children (7–9). Studies of the associ-
ations between these FTO and MC4R variants and body
weight or BMI across the life course may provide insights into
their mechanisms of action and also into the possible relevance
of their related eating behaviour phenotypes in different age
populations.Further,variationsinthestrengthofgeneticassoci-
ations by age may contribute to the failure to replicate
genetic-association ﬁndings (10). However, few studies have
been able to investigate the longitudinal pattern of association
between these genetic variants and BMI across childhood, ado-
lescence and adulthood.
We therefore genotyped variants in FTO and MC4R in the
MRC National Survey of Health and Development, which
has measured its participants’ heights and weights repeatedly
from age 2 years to age 53 years (11). In particular we
assessed whether the genetic associations with body weight
and BMI differed with age through childhood and adult life.
RESULTS
Genotype data were available in 1240 men and 1239 women
(1233 men and 1233 women for FTO rs9939609; 1235 men
and 1234 women for MC4R rs17782313). Of these, 839
(34%) had BMI measured at all 11 ages from 2 to 53 years
and 2126 (86%) at eight or more ages. Only 81 (3%) contrib-
uted fewer than ﬁve measurements. The number of individuals
with BMI recorded was lowest at ages 2 (n ¼ 1930), 15 (n ¼
1903) and 20 (n ¼ 1968) years. At all other ages, over 2000
measurements were available for analysis. Compared with
those excluded because of missing genotype data, the included
individuals had slightly heavier birth weights (men P ¼ 0.03;
women P ¼ 0.04) and included women were slightly taller
throughout life (age 4 years P ¼ 0.04; age 11 years P ¼
0.01; age 15 years P ¼ 0.03; adult height P ¼ 0.01). No
differences in any other growth parameters were observed
(Table 1).
Associations with FTO rs9939609
In cross-sectional analyses, the FTO rs9939609 ‘A’ allele was
positively associated with BMI from ages 11 to 36 years, with
similar trends with BMI also observed at ages 7, 43 and
53 years (Table 2, Fig. 1). At almost all ages, cross-sectional
associations with weight SDS were similar to, but weaker
than, those with BMI SDS (Fig. 1).
Table 1. Mean (SD) for weight, height and BMI at 12 time-points between birth to age 53 years in men and women with genotype data (‘included’)
Included Excluded
Men Women Men Women
N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD)
Weight (kg)
Birth 1229 3.47 (0.52) 1230 3.32 (0.48) 1568 3.42 (0.58) 1300 3.28 (0.55)
2 years 1037 13.2 (1.5) 1010 12.6 (1.5) 1126 13.2 (1.5) 943 12.6 (1.6)
4 years 1112 17.5 (2.1) 1098 17.0 (2.1) 1184 17.5 (2.1) 995 16.9 (2.3)
6 years 1045 20.9 (2.5) 1046 20.4 (2.6) 1103 20.9 (2.5) 894 20.2 (2.9)
7 years 1021 23.0 (2.9) 1027 22.6 (3.1) 1046 23.1 (3.0) 906 22.5 (3.5)
11 years 1045 34.3 (5.9) 1020 35.0 (6.6) 1020 34.3 (6.1) 875 34.8 (7.7)
15 years 968 51.8 (9.4) 947 51.9 (8.1) 931 51.7 (9.7) 771 51.8 (9.7)
20 years 978 70.7 (9.1) 1013 57.9 (8.4) 884 71.1 (9.3) 746 57.6 (8.7)
26 years 1050 73.5 (10.1) 1076 59.1 (8.8) 773 73.7 (9.9) 706 58.8 (9.9)
36 years 1100 76.2 (11.0) 1125 62.1 (10.4) 539 76.8 (12.2) 533 62.2 (12.9)
43 years 1141 78.8 (11.6) 1167 66.3 (12.0) 476 79.5 (13.3) 453 66.4 (14.7)
53 years 1224 83.5 (13.2) 1221 71.5 (13.9) 227 84.3 (15.7) 281 72.0 (16.4)
Height (cm)
2 years 1025 85.9 (5.2) 978 84.8 (4.5) 1112 85.9 (5.3) 895 84.6 (5.1)
4 years 1085 103.5 (5.1) 1077 102.9 (5.0) 1162 103.6 (5.2) 960 102.4 (5.3)
6 years 1048 114.5 (5.3) 1041 113.8 (5.3) 1091 114.5 (5.2) 881 113.5 (5.6)
7 years 1064 120.4 (5.7) 1066 119.7 (5.4) 1083 120.4 (5.4) 927 119.3 (6.1)
11 years 1052 140.7 (6.8) 1029 141.2 (6.8) 1030 140.8 (6.6) 884 140.8 (6.6)
15 years 968 162.0 (9.1) 950 158.8 (6.1) 945 162.0 (8.7) 776 158.1 (6.5)
Adult 1099 175.3 (6.5) 1125 162.6 (5.8) 537 175.3 (6.8) 530 161.8 (6.6)
BMI (kg/m
2)
2 years 985 18.0 (2.5) 933 17.6 (2.4) 1061 18.0 (2.6) 861 17.7 (2.5)
4 years 1066 16.3 (1.6) 1046 16.0 (1.6) 1132 16.3 (1.7) 940 16.1 (1.7)
6 years 999 15.9 (1.3) 1000 15.7 (1.4) 1051 15.9 (1.3) 841 15.7 (1.5)
7 years 1017 15.9 (1.3) 1022 15.7 (1.5) 1040 15.9 (1.3) 898 15.7 (1.7)
11 years 1038 17.3 (2.1) 1017 17.5 (2.5) 1012 17.3 (2.2) 870 17.5 (2.8)
15 years 953 19.6 (2.4) 939 20.6 (2.8) 928 19.6 (2.5) 761 20.7 (3.3)
20 years 958 22.6 (2.4) 999 21.9 (2.9) 871 22.7 (2.5) 736 21.8 (2.9)
26 years 1050 23.4 (2.8) 1076 22.4 (3.1) 772 23.5 (2.9) 706 22.4 (3.5)
36 years 1096 24.8 (3.1) 1122 23.5 (3.7) 535 24.9 (3.5) 527 23.7 (4.7)
43 years 1141 25.7 (3.4) 1159 25.1 (4.5) 475 25.9 (3.9) 450 25.4 (5.5)
53 years 1224 27.4 (3.9) 1219 27.4 (5.2) 227 27.5 (4.6) 278 27.9 (6.4)
Similar data are also shown for men and women without genotype data (‘excluded’) for comparison.
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0.019, 95% CI: 0.011–0.026), P , 0.001), quadratic
(regression coefﬁcient ¼ 20.00065, 95% CI: 20.0010 to
20.00032, P , 0.001) and cubic (regression coefﬁcient ¼
0.0000062, 95% CI: 0.0000023–0.000010, P ¼ 0.002)
genotype-by-age interaction terms were all signiﬁcant. Esti-
mation of mean BMI SDS by genotype using the polynomial
model indicated that the association between FTO rs9939609
and BMI was greatest at around age 20 years (Fig. 2A). In a
linear piecewise model, the association strengthened between
ages 2 and 20 years (P , 0.001 for genotype-by-age inter-
action) at a rate of 0.007 SDS per A-allele per year (95%
CI: 0.003–0.010), and reached a peak at age 20 years (0.13
SDS per A-allele, 95% CI: 0.08–0.19) (Table 3). Thereafter,
the association with BMI SDS weakened with age from 20
to 53 years (rate of decline: 20.003 SDS per A-allele per
year, 95% CI: 20.005 to 20.001, P ¼ 0.001 for genotype-
by-age interaction) (Table 3), and by age 53 years there was
only a weak association between FTO rs9939609 and BMI
SDS (0.05 SDS per A-allele, 95% CI: 20.01 to 0.10).
A similar pattern, although with slightly weaker change with
age, was observed for weight (Table 3, Fig. 1).
There were no associations between FTO rs9939609 and
childhood height, and only a weak inverse trend with adult
height (P ¼ 0.3, Fig. 1).
Associations with MC4R rs17782313
In cross-sectional analyses, the MC4R rs17782313 ‘C’ allele
was positively associated with BMI SDS from ages 11 to 43
years (except at age 36 years P ¼ 0.09) (Table 2). Cross-
sectional associations with weight SDS were stronger than
those with BMI SDS, and were apparent from age 6 years,
with similar trends even at ages 2 years (P ¼ 0.1) and
4 years (P ¼ 0.1) (Fig. 1).
In longitudinal analyses, linear (regression coefﬁcient ¼
0.013, 95% CI: 0.007–0.019, P , 0.001), quadratic
(regression coefﬁcient ¼ 20.00049, 95% CI: 20.00077 to
20.00022, P , 0.001) and cubic (regression coefﬁcient ¼
0.0000050, 95% CI: 0.0000016–0.0000085, P ¼ 0.004)
genotype-by-age interaction terms were signiﬁcant; predic-
tions from these polynomial models of mean weight SDS by
genotype indicated that the association between MC4R
rs17782313 and weight SDS peaked between ages 15 and
20 years (Fig. 2B). In the linear piecewise model, the associ-
ation strengthened between birth and age 20 years (P ¼ 0.006
for genotype-by-age interaction) at a rate of 0.005 SDS per
C-allele per year (95% CI: 0.001–0.008), so that at age 20
years there was a 0.13 SDS increase in mean weight per
C-allele (95% CI: 0.06–0.19) (Table 3). Thereafter, the
association with weight SDS weakened with age (rate of
decline: 20.002 SDS per C-allele per year, 95% CI:
20.004 to 0.000, P ¼ 0.05 for genotype-by-age interaction)
(Table 3), but the association with weight was still apparent
at age 53 years (0.08 SDS per C-allele, 95% CI: 0.02, 0.14).
In contrast to the FTO variant, MC4R rs17782313 was posi-
tively associated with height from age 7 years onwards (0.07
SDS per C-allele in adulthood, 95% CI: 0.01, 0.14) (Fig. 1).
In longitudinal analyses, the association with height SDS
strengthened between ages 2 and 20 years (P ¼ 0.02 for
genotype-by-age interaction) by 0.004 SDS per C-allele per
year (95% CI: 0.001–0.007) (Table 3); although most of
this change had appeared by age 7 years, and the association
with height SDS appeared to remain constant between age
7 years to adulthood (Fig. 1). In longitudinal polynomial
analyses, linear (regression coefﬁcient ¼ 0.016, 95%
Table 2. Mean (95% conﬁdence interval) BMI at 11 time-points between ages 2 and 53 years by FTO rs9939609 or MC4R rs17782313 genotype
N BMI (kg/m
2) P-value 
FTO rs9939609 TT TA AA
2 years 1918 17.8 (17.6,18.0) 17.8 (17.7,18.0) 17.8 (17.6,18.1) 0.7
4 years 2112 16.2 (16.0,16.3) 16.2 (16.1,16.3) 16.2 (16.1,16.4) 0.5
6 years 1999 15.8 (15.7,15.9) 15.8 (15.7,15.9) 15.8 (15.7,16.0) 0.9
7 years 2039 15.7 (15.6,15.8) 15.8 (15.7,15.9) 15.8 (15.7,16.0) 0.2
11 years 2055 17.2 (17.0,17.3) 17.4 (17.2,17.5) 17.7 (17.5,18.0) 0.001
15 years 1892 19.9 (19.7,20.1) 20.0 (19.9,20.2) 20.6 (20.3,20.9) 0.001
20 years 1957 22.0 (21.8,22.2) 22.2 (19.9,20.2) 22.9 (22.5,23.2) ,0.001
26 years 2126 22.7 (22.5,22.9) 22.9 (22.7,23.0) 23.4 (23.0,23.8) 0.001
36 years 2218 24.0 (23.7,24.2) 24.1 (23.8,24.3) 24.6 (24.2,25.0) 0.02
43 years 2300 25.3 (25.0,25.6) 25.3 (25.1,25.5) 25.7 (25.3,26.1) 0.1
53 years 2443 27.2 (26.9,27.5) 27.4 (27.1,27.6) 27.7 (27.3,28.2) 0.07
MC4R rs17782313 TT TC CC
2 years 1924 17.8 (17.6,17.9) 17.8 (17.6,18.0) 18.3 (17.8,18.8) 0.3
4 years 2115 16.1 (16.0,16.2) 16.2 (16.1,16.3) 16.4 (16.1,16.7) 0.09
6 years 2003 15.8 (15.7,15.9) 15.8 (15.7,15.9) 16.0 (15.7,16.2) 0.4
7 years 2043 15.8 (15.7,15.9) 15.8 (15.7,15.9) 15.8 (15.5,16.2) 0.6
11 years 2058 17.2 (17.1,17.4) 17.5 (17.3,17.7) 17.7 (17.3,18.2) 0.005
15 years 1897 20.0 (19.8,20.1) 20.2 (20.0,22.5) 20.4 (19.9,21.0) 0.05
20 years 1961 22.1 (21.9,22.2) 22.3 (22.2,22.5) 22.7 (22.0,23.3) 0.01
26 years 2131 22.8 (22.6,23.0) 22.9 (22.7,23.1) 23.5 (22.8,24.2) 0.02
36 years 2222 24.0 (23.9,24.2) 24.2 (23.9,24.5) 24.5 (23.9,25.2) 0.09
43 years 2302 25.2 (25.0,25.4) 25.5 (25.2,25.8) 26.0 (25.2,26.7) 0.02
53 years 2446 27.3 (27.0,27.5) 27.4 (27.1,27.7) 27.8 (27.0,28.5) 0.09
 From additive models adjusted for sex.
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coefﬁcient ¼ 20.0007, 95% CI: 20.0012 to 20.00002,
P , 0.001) genotype-by-age interaction terms were signiﬁcant
for the association between MC4R rs17782313 and height
SDS.
DISCUSSION
In a unique study of a longitudinal birth cohort born in 1946
and followed through to age 53 years, we observed that the
associations of FTO rs9939609 and MC4R rs17782313 on
body size varied with age. The changes with age appeared
to be biphasic, in that the associations with both variants
strengthened during childhood and adolescence, the associ-
ations peaked in early adulthood and thereafter weakened
with increasing adult age. Associations with FTO rs9939609
were most apparent with BMI, whereas, MC4R rs17782313
was positively associated with childhood and adult height
and therefore showed stronger associations with body weight
than with BMI.
The main strength of this study was the availability of longi-
tudinal data on weight and height across childhood, adoles-
cence and adulthood up to age 53 years, which allowed a
unique exploration of the life course genetic associations
with body size. Weight and height were measured at all
ages, except at ages 20 and 26 years, when they were self-
reported. Despite the reliance on self-reported measures at
those ages, the peak associations between FTO rs9939609
and BMI SDS, and between MC4R rs17782313 and weight
SDS, were both seen at age 20 years. Differential mis-
reporting of body size by genotype seems unlikely, but if
heavier individuals were more likely to under-report their
weight than others it is possible that the peak associations
and the rates of change in associations with age may be down-
wardly biased. Our statistical models included individuals
without complete outcome data and therefore assumed data
to be missing at random. This is a reasonable assumption in
the sample studied given that the DNA was collected at the
most recent contact with participants and hence the sample
represents those still alive and in the study at age 53 years.
Those with missing genetic information had similar mean
body size measures at most ages compared with those included
in the analysis.
There have been only a few other studies exploring the vari-
ations in these genetic associations over the life course. In
older adults, a study of men in the Health Professionals
Follow-Up Study reported that, similar to our ﬁndings, associ-
ations between the same FTO rs9939609 variant and BMI
Figure 1. Cross-sectional associations between FTO rs9939609 and MC4R rs17782313 with weight, BMI and height standard deviation scores (SDS) at up to
12 different time-points from birth to age 53 years. Error bars represent regression coefﬁcient and 95% CI from additive genetic models.
548 Human Molecular Genetics, 2010, Vol. 19, No. 3declined with age. However, in the same report those age
effects were not seen in women in the Nurses Health Study
(12). Rather, in those women carriers of the MC4R
rs17782313 C-allele showed greater gains in adult weight
and BMI than non-carriers (13). In both of those populations,
heights and weights were self-reported and follow-up only
started in adulthood at mean age 56 years in men and
44 years in women (14). In the NSHD we found no evidence
of differences between men and women in the genetic associ-
ations with body size across the life course. In a study of 1629
Danish men, born between 1943 and 1977, the FTO rs9939609
AA genotype was associated with faster weight gain from
birth to age 7 years, but not with further weight gain during
childhood and adolescence. Subsequently, in contrast to our
ﬁndings, the AA genotype was associated with a second
increase in BMI z-score, from ages 13 or 20 years up to age
35 years (14). However, in that Danish study, half of the men
were selected for the presence of adult obesity (above the
99th percentile), and it is possible that the effect of the FTO
rs9939609 variant on BMI or weight gain might be greater in
individuals with obesogenic lifestyles, such as sedentary beha-
viours (15,16). Finally, consistent with our current ﬁndings, a
study of .7000 UK twins described that the association
between the FTO rs9939609 variant and BMI was not apparent
at age 4 years, but became increasingly stronger at ages 7–11
years, in parallel with a rise in the heritability of BMI from
48% at age 4 years to 78% at age 11 years (17).
Although our cohort was sampled from a national popu-
lation, even such representative cohorts will have mean BMI
trajectories which differ from cohorts born earlier or later
(18). NSHD cohort members were all born during 1 week in
1946 and experienced post-war rationing during the ﬁrst
8 years of life, which could have diminished the genetic differ-
ences in early childhood weight gain and BMI. The prevalence
of overweight or obesity in this cohort remained low during
childhood and adolescence until the onset of the obesogenic
environment in the 1980s when cohort members were aged
30–40 years old (18). Our current observed weakening of
the genetic associations with FTO and MC4R variants across
mid-life could therefore reﬂect the increasing impact of
environmental inﬂuences on physical activity and food con-
sumption coincident with the onset of the obesity epidemic
(18). However, in a single study where all the participants
were born in the same era it is difﬁcult to disentangle age
effects from period effects.
Recent studies have found several further common variants
associated with BMI and obesity risk (19–22). Further longi-
tudinal studies of those variants would help to show whether
the biphasic changes with age that we identiﬁed with both
the FTO and MC4R variants are generalizable observations,
possibly reﬂecting age-related trends in the heritability of
BMI and obesity risk. Variants in PCSK1, which encodes an
enzyme that converts prohormones into key functional regula-
tors of appetite (22,23), demonstrated age-dependent effects
on obesity risk in the EPIC-Norfolk Study, being apparent
only in younger individuals (aged below the median age 59
years) (24). However, that analysis was based on cross-
sectional data where it is not possible to separate age-effects
from birth-cohort effects. The importance of longitudinal
data in the detection of age-related effects is highlighted by
a recent study of the penetrance of rare deleterious mutations
in MC4R on the development of monogenic obesity (25). In
cross-sectional inter-generational comparisons, the prevalence
of obesity among carriers of MC4R mutations reduced with
age, from 79% in children, to 60% in 18–52-year-old adults,
and 40% in adults aged .52 years, suggesting that these
mutations had lower penetrance among older birth cohorts.
In contrast, in their longitudinal analysis, the prevalence of
obesity increased from 37% at 20 years to 60% at .40
years, indicating that the penetrance of these mutations
increased with age (25). Further longitudinal population-based
studies spanning a wide range of birth years are therefore
required to distinguish between the effects of age and period
changes in the obesogenic environment.
In conclusion, genetic variants in FTO and MC4R showed
biphasic changes in their associations with BMI and weight,
Figure 2. Linear prediction of mean and 95% prediction interval from additive
genetic models for (A) BMI SDS by FTO rs9939609 genotype; (B) Weight
SDS by MC4R rs17782313 genotype.
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years, and then weakening with increasing adult age. We pos-
tulate that these changes may reﬂect the age-dependent inﬂu-
ence of satiety and eating behaviour on weight gain and BMI,
as weight gain in adult life may be increasingly determined or
modiﬁed by other hedonic, psycho-social or environmental
inﬂuences (26). Future studies of the aetiology of obesity span-
ning different age groups may identify age-speciﬁc genetic or
other determinants of weight gain.
MATERIALS AND METHODS
The MRC National Survey of Health and Development is a
socially stratiﬁed birth cohort of 2547 women and 2815
men, who have been followed up since their birth in 1946
with regular data collections (11). The most recent contact
was when cohort members were aged 53 years of age and
3035 (1472 men, 1563 women) provided information. The
majority (n ¼ 2989) were interviewed and examined in their
own homes by trained research nurses with others completing
a postal questionnaire (n ¼ 46). Those interviewed at the age
of 53 years were, in most respects, representative of the
native born population of that age (27). Contact was not
attempted for the 1979 individuals who had previously
refused to take part, were living abroad, were untraced since
last contact at 43 years or had already died. Blood samples
were collected from 2756 members. The data collection
received MREC approval, and informed consent was given
by respondents to each set of questions and measures.
Anthropometry
Birth weight of cohort members to the nearest quarter of a
pound was extracted from medical records within a few
weeks of delivery and converted into kilograms. Height and
weights were measured using standardized protocols at ages
2, 4, 6, 7, 11 and 15 years and at 36, 43 and 53 years.
Height and weight were self-reported at ages 20 and 26
years. BMI, deﬁned as weight/height
2, was calculated at
each age.
Genotyping
DNA was extracted and puriﬁed from whole blood using the
Puregene DNA Isolation Kit (Flowgen, Leicestershire, UK)
according to the manufacturer’s protocol. The two SNPs were
typed by Source Bioscience PLC using the Applied Biosystems
(Foster City, CA, USA) SNPlex technology which is a based on
an Oligonucleotide Ligation Assay combined with multiplex
PCR ampliﬁcation and capillary electrophoresis. Genotyping
was performed using an ABI 3730xl DNA Analyser and ABI
GeneMapper v4.0 software. The integrity of the genotyping
was checked by genotyping frequency, concordance of dupli-
cates and Hardy–Weinberg equilibrium (HWE). The call
rates for rs9939609 and rs17782313 were 99.5 and 99.6%,
respectively, with .95% concordance between duplicate
samples and there was no evidence of deviation from HWE
(P . 0.05). The minor allele frequency for FTO rs9939609
was 0.41 and for MC4R rs17782313 it was 0.24.
Statistical methods
Sex speciﬁc standard deviation scores (SDS) for height,
weight and BMI were estimated using internally generated
growth charts. The growth charts were constructed using
the LMS (L ¼ skewness; M ¼ median; S ¼ coefﬁcient of
variation) method (28). This is preferable to the use of an
external reference, which can be misleading for historical
cohorts (29).
In initial descriptive analyses, cross-sectional associations
between each genotype and height, weight and BMI SD
scores at each age were performed using linear regression
assuming an additive genetic model, with adjustment for sex.
Table 3. Results from hierarchical mixed models for the longitudinal associations between FTO and MC4R variants with weight, BMI and height SDS
(a) FTO rs9939609 N Mean (95% CI) per A-allele P-value
BMI SDS Genotype (age 2 years) 2466 0.01 (20.04,0.06) 0.6
Genotype   age (2–20) (change per year 2–20 years) 0.007 (0.003,0.010) ,0.001
Genotype   age (20–53) (change per year 20–53 years) 20.003 (20.005, 20.001) 0.001
Weight SDS Genotype (birth) 2466 0.00 (20.04,0.05) 0.9
Genotype   age (birth-20) (change per year 0–20 years) 0.004 (0.001,0.007) 0.005
Genotype   age (20–53) (change per year 20–53 years) 20.002 (20.004, 20.000) 0.02
Height SDS Genotype (age 2 years) 2450 20.02 (20.07,0.04) 0.6
Genotype   age (2–20)  (change per year 2–20 years) 20.001 (20.004,0.002) 0.4
(b) MC4R rs17782313 N Mean (95% CI) per C-allele P-value
BMI SDS Genotype (age 2 years) 2469 0.04 (20.01,0.10) 0.2
Genotype   age (2–20) (change per year 2–20 years) 0.002 (20.002,0.006) 0.3
Genotype   age (20–53) (change per year 20–53 years) 20.001 (20.003,0.001) 0.3
Weight SDS Genotype (birth) 2469 0.04 (20.01,0.09) 0.1
Genotype   age (birth-20) (change per year 0–20 years) 0.005 (0.001,0.008) 0.006
Genotype   age (20–53) (change per year 20–53 years) 20.002 (20.004,0.000) 0.05
Height SDS Genotype (age 2 years) 2453 0.02 (20.04,0.08) 0.5
Genotype   age (2–20)  (change per year 2–20 years) 0.004 (0.001,0.007) 0.02
Regression coefﬁcients presented represent the main effect of genotype and genotype-by-linear age interactions.
 Final adult height (from measure at 36 years) was assumed to have been reached at 20 years.
550 Human Molecular Genetics, 2010, Vol. 19, No. 3Longitudinal analyses were performed using hierarchical
mixed models. These models take account of the correlation
between repeated measures on the same individual and
allow for incomplete outcome data on the assumption that
data are missing at random. To initially test whether the
association between genotype and each measure of body size
(BMI, weight and height) changed with age, we ﬁrst ﬁtted
linear age and genotype-by-age interaction terms, then
added, in turn, quadratic and cubic ages and their interactions
with genotype. For simplicity of presentation, and because the
ﬁndings were very similar to those from the polynomial age
models, we then ﬁtted linear piecewise models with a knot
at 20 years to allow different slopes for childhood (2–20
years) and adulthood (20–53 years) for BMI. The intercept
was allowed to vary according to allele frequency in an addi-
tive genetic model. Genotype-by-linear age interaction terms
(one for 2–20 years and another for 20–53 years) were then
added to the model to assess whether the effect of genotype
changed with increasing age. Likelihood ratio tests were
used to assess the improvement in ﬁt on addition of each
new term in the model. We allowed for a random intercept
and random slopes. For the weight trajectories, similar
models were ﬁtted except that baseline was taken as birth,
due to the availability of birth weight data. For height, baseline
was at age 2 years and change in height was modelled only to
adulthood using a single slope. Because the ﬁrst two measures
of adult height (at age 20 and 26 years) were self-reported,
height at 36 years was used as ﬁnal attained adult height and
was assumed to have been achieved by age 20 years.
Tests for sex interactions were not statistically signiﬁcant,
and therefore all models included both men and women and
were adjusted for sex. Analyses were performed using Stata
version 10.1.
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